TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
166,958
|
147,146
|
140,976 |
Financial expenses |
2,019
|
1,103
|
687 |
Earnings before taxes |
12,841
|
9,206
|
7,401 |
EBITDA |
19,706
|
13,816
|
11,988 |
Total assets |
145,123
|
131,899
|
124,429 |
Current assets |
58,272
|
60,713
|
51,519 |
Current liabilities |
30,018
|
35,628
|
23,385 |
Equity capital |
78,697
|
69,564
|
69,236 |
- share capital |
336
|
334
|
364 |
Employees (average) |
79
|
76
![]() |
76 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
54.2%
|
52.7%
|
55.6% |
Turnover per employee |
2,113
|
1,936
|
1,855 |
Profit as a percentage of turnover |
7.7%
|
6.3%
|
5.2% |
Return on assets (ROA) |
10.2%
|
7.8%
|
6.5% |
Current ratio |
194.1%
|
170.4%
|
220.3% |
Return on equity (ROE) |
16.3%
|
13.2%
|
10.7% |
Change turnover |
19,055
|
17,589
|
20,616 |
Change turnover % |
13%
|
14%
|
17% |
Chg. No. of employees |
3
|
0
|
2 |
Chg. No. of employees % |
4%
|
0%
|
3% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.